[
  {
    "ts": null,
    "headline": "EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight",
    "summary": "DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets [the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].",
    "url": "https://finnhub.io/api/news?id=e3dda1a4e7ead2ec85041f14b3ce46ad6dd16260d2e7a21c41bc9d07feffa7fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770849060,
      "headline": "EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight",
      "id": 139050616,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets [the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].",
      "url": "https://finnhub.io/api/news?id=e3dda1a4e7ead2ec85041f14b3ce46ad6dd16260d2e7a21c41bc9d07feffa7fd"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=50c80a008820203a83f977aeb697bbb7e2c115ab4c0b1c200ea3d868f9fa77fd",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770827820,
      "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "id": 139062286,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=50c80a008820203a83f977aeb697bbb7e2c115ab4c0b1c200ea3d868f9fa77fd"
    }
  },
  {
    "ts": null,
    "headline": "2 Urgent Sells And 2 No Brainer Dividend Buys",
    "summary": "It is in our best approach to sell high and buy low. Here's how to approach it systematically today with 2 SELLS and 2 BUYS. Read the full article here.",
    "url": "https://finnhub.io/api/news?id=710180ef6607cf998857b15aaa54b1cbd366e4e984f58dca1a1a55930c6f0ac2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770826010,
      "headline": "2 Urgent Sells And 2 No Brainer Dividend Buys",
      "id": 139048960,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2396885/image_2396885.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "It is in our best approach to sell high and buy low. Here's how to approach it systematically today with 2 SELLS and 2 BUYS. Read the full article here.",
      "url": "https://finnhub.io/api/news?id=710180ef6607cf998857b15aaa54b1cbd366e4e984f58dca1a1a55930c6f0ac2"
    }
  },
  {
    "ts": null,
    "headline": "Best Stocks Outside The Mag 7 To Balance Growth And High Yield",
    "summary": "Look beyond the Mag 7 for the best stocks to buy in 2026, balancing AI beneficiaries with income stocks in a barbell approach. Click here to see the top 6 stocks.",
    "url": "https://finnhub.io/api/news?id=2a160019034969ea1bcda562f092e7064b57bbfccfa54a6460cdc3602d6cda26",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770825639,
      "headline": "Best Stocks Outside The Mag 7 To Balance Growth And High Yield",
      "id": 139048966,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1458140515/image_1458140515.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Look beyond the Mag 7 for the best stocks to buy in 2026, balancing AI beneficiaries with income stocks in a barbell approach. Click here to see the top 6 stocks.",
      "url": "https://finnhub.io/api/news?id=2a160019034969ea1bcda562f092e7064b57bbfccfa54a6460cdc3602d6cda26"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=8afdd7b9a4f907c1c4c4f874513264647314ff7ad7acf5c0117b81f80d1be998",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770818405,
      "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 139046532,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=8afdd7b9a4f907c1c4c4f874513264647314ff7ad7acf5c0117b81f80d1be998"
    }
  },
  {
    "ts": null,
    "headline": "Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award",
    "summary": "Bristol Myers Squibb Foundation is proud to support Conquer Cancer's EveryGrant and the American Heart Association to Advance Clinical Trials Leadership in Oncology and Cardiovascular Research Originally published by The Robert A. Winn Excellence ...",
    "url": "https://finnhub.io/api/news?id=ab838e01bf198e0cfeae474cec208056dfa67d5b28151f357f69ac6bbd0c89a6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770811200,
      "headline": "Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award",
      "id": 139042333,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers Squibb Foundation is proud to support Conquer Cancer's EveryGrant and the American Heart Association to Advance Clinical Trials Leadership in Oncology and Cardiovascular Research Originally published by The Robert A. Winn Excellence ...",
      "url": "https://finnhub.io/api/news?id=ab838e01bf198e0cfeae474cec208056dfa67d5b28151f357f69ac6bbd0c89a6"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff",
    "summary": "All eyes should be on Bristol-Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.",
    "url": "https://finnhub.io/api/news?id=998c1f1316cfb5204c61b1045a95674a0852fcfbc9266365137c83389a04252f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770804000,
      "headline": "Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff",
      "id": 139044801,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/158759380/image_158759380.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "All eyes should be on Bristol-Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.",
      "url": "https://finnhub.io/api/news?id=998c1f1316cfb5204c61b1045a95674a0852fcfbc9266365137c83389a04252f"
    }
  }
]